SCHEMBL31701825

SCHEMBL31701825

CC(C)(C)OC(=O)N1CC=C(N2CC=C(c3ccc([N+](=O)[O-])cc3F)CC2)C(F)(F)C1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ PDK4 Q16654 1/20 0.39
▸ ADAM10 O14672 1/20 0.37
▸ ERBB2 P04626 1/20 0.37
▸ GRM5 P41594 5/20 0.37
▸ GRM1 Q13255 5/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TNF P01375 1/20 0.36
▸ HTR6 P50406 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ WDR5 P61964 2/20 0.35
▸ CDK9 P50750 2/20 0.34
▸ THRB P10828 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ CCNT1 O60563 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10036179 0.86 PDK4 (0.51) ALDH1A1MAPTLMNAPDK4GRM5
SCHEMBL29535433 0.86 PDK4 (0.51) ALDH1A1MAPTLMNAPDK4GRM5
SCHEMBL30255499 0.84 ALDH1A1 (0.49) ALDH1A1MAPTLMNAKMT2ATHRB
SCHEMBL23783392 0.83 ALDH1A1 (0.45) ALDH1A1MAPTLMNAGRM5GRM1
SCHEMBL30207477 0.83 ALDH1A1 (0.45) ALDH1A1MAPTLMNAGRM5GRM1
SCHEMBL31334845 0.82 ALDH1A1 (0.45) ALDH1A1MAPTLMNAGRM5GRM1
SCHEMBL31334497 0.81 ALDH1A1 (0.44) ALDH1A1MAPTLMNAPDK4ADAM10
SCHEMBL31334835 0.79 ALDH1A1 (0.39) ALDH1A1MAPTLMNAPDK4ADAM10
SCHEMBL31630903 0.78 PDK4 (0.51) ALDH1A1MAPTLMNAPDK4GRM5
SCHEMBL5004734 0.78 PDK4 (0.51) ALDH1A1MAPTLMNAPDK4GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014147-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2026-01-15 — — US disclosed
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 — — US disclosed
US-20250320205-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 — — US disclosed
US-20250320206-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 ALDH1A1 959/4885MAPT 1017/4885LMNA 2978/4885
US-20250320205-A1 STAT6 DEGRADERS STAT6, STAT1, STAT5B ALDH1A1 1225/4885MAPT 1034/4885LMNA 2666/4885
US-20260014147-A1 STAT6 DEGRADERS STAT6, NCOR1, CBR1 ALDH1A1 1790/4885MAPT 4225/4885LMNA 1900/4885
US-20250320206-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 ALDH1A1 959/4885MAPT 1017/4885LMNA 2978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback